Bienvenidos a La Fundación Internacional del Dolor

Horario : Miercoles - 10:00 am a 14:00 pm
  Contacto : +34 91 622 04 09

Bibliografía consultada para toda la investigación de vulvodinia

Bibliografía consultada para toda la investigación de vulvodinia

 

1.- Heraso MI. Bloqueos nerviosos e infiltraciones: Tratamiento médico del Dolor Crónico Benigno 2014; 04:30-32; 16:97-105; 18:113; 26:159-161

2.- Heraso MI. El sexo en la mujer: Practicas sexuales. Estudio y tratamiento del dolor vulvovaginal. ed FID, 2008;

3.- Haefner HK. Report of the International Society for the Study of Vulvovaginal Disease: terminology and classification of vulvodynia. J Low Genit Tract Dis. 2007;11:48–49.

4.- Edwards L. Subsets of vulvodynia: overlapping characteristics. J Reprod Med. 2004;49:883–887.

5.- Clare CA, Yeh J. Vulvodynia in adolescence: childhood vulvar pain syndromes. J Pediatr Adolesc Gynecol. 2011;24:110–115.

6.- Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic char acteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol. 2012;206:170. e1–e9.

7.- Moyal-Barracco M, Labat JJ. Vulvodynia and chronic pelvic and perineal pain. Prog Urol. 2010;20:1019–1026.

8.- Xie Y, Shi L, Xiong X, Wu E, Veasley C, Dade C. Economic burden and quality of life of vulvodynia in the United States. Curr Med Res Opin. 2012;28:601–608.

9.- Sadownik LA. Clinical profile of vulvodynia patients: a prospective study of 300 patients. J Reprod Med. 2000;45:679–684.

10.- Nunns D, Mandal D. Psychological and psychosexual aspects of vulvar vestibulitis. Genitourin Med. 1997;73:541–544.

11.- Arnold L, Bachmann GA, Rosen R, Kelly S, Rhoads GG. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol. 2006;107:617–624.

12.- Ehrstrom S, Kornfeld D, Rylander E, Bohm-Starke N. Chronic stress in women with localised provoked vulvodynia. J Psychosom Obstet Gynaecol. 2009;30:73–79.

13.- Schover LR, Youngs DD, Cannata R. Psychosexual aspects of the evaluation and management of vulvar vestibulitis. Am J Obstet Gynecol. 1992;167:630–636.

14.- Gates EA, Galask RP. Psychological and sexual functioning in women with vulvar vestibulitis. J Psychosom Obstet Gynaecol. 2001;22:221–228.

15.- Skene AJ. Treatise on the diseases of women, for the use of students and practitioners. New York: Appleton & Company, 1889.

16.- Thomas TG, Munde PF: Hyperaesthesia of vulva. The Diseases of Women. Philadelphia:Lea Brothers & Co.1891.

17.- Kelly HA: Gynecology. New York: Appleton & Company. 1928.

18.- Marin MG, King R, Sfameni S, Dennerstein G. Adverse behavioral and sexual factors in chronic vulvar disease. Am J Obstet Gynecol 2000;183(1):34-8.

19.- Turna R, Bornstein J. Vulvar pain syndrome (vulvodynia)-dilemmas in terminology. Harefuah 2006;145(3):215-8

20.- Hallado en: http://www.icd9data.com/2009/Volu-me1/580-629/617-629/625/default.htm

21.- Boardmen LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol 2008;112(3):579-85.

22.- Goetsch MF. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 1991; 164:1609-14.

23.- Aikens, J.E., Reed, B.D., Gorenflo, D.W. and Haefner, H.K., Depressive symptoms among women with vulvar dysesthesia, Am J Obstet Gynecol, 189 (2003) 462-6.

24.- Pukall C, Kandyba K, Amsel R, Khalifé S, Binik Y. Effectiveness of hypnosis for the treatment of vulvar vestibulitis syndrome: a preliminary investigation.J Sex Med. 2007 Mar;4(2):417-25.

25.- Green J, Hetherton J.Psychological aspects of vulvar vestibulitis syndrome.J Psychosom Obstet Gynaecol. 2005 Jun; 26(2):101-6. Review.

26.- Ramakers MJ, van Lunsen HW.[Vulvodynia caused by vulvar vestibulitis syndrome].Ned Tijdschr Geneeskd. 1997 Nov 1; 141(44):2100-5. Review.

27.- Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003; 58:82-8.

28.- Arnold LD, Bachmann GA, Rosen R, Rhoads GG. Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. Am J Obstet Gynecol 2007; 196(2): 128.

29.- Reed BD, Haefner HK, Sen A, Gorenflo DW. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol 2008;112(2 Pt 1):231-7.

30.- Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?. J Am Med Womens Assoc 2003;58(2):82-8

31.- Resident Population Estimates of the United States by Age and Sex. ApriM, 1990-July 1,1999. Washington DC: Population Estimates Program, Population Division, US Census Bureau; 2000.

32.- Goetsch MF. Vulvar vestibulitis: Prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 1991; 164(6 Pt 1): 1609-14.

33.- Reed BD, Cantor LE. Vulvodynia in preadolescent girls. J Low Genit Tract Dis 2008; 12(4):257-61.

34.- Lavy RJ, Hynan LS, Haley RW. Prevalence of vulvar pain in an urban, minority population. J Reprod Med2007;52(1):59-62.

35.- ACOG Committee on Gynecologic Practice. ACOG Committee Opinion: Number 345, October 2006: Vulvodynia. Obstet Gynecol 2006; 108(4): 1049-52.

36.- Foster DC. Vulvar disease. Obstet Gynecol 2002;100(1):145-63.

37.- Smart OC, MacLean AB. Vulvodynia. Curr Opin Obstet Gynecol 2003;15(6):497-500.

38.- Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002;186(4):696-700.

39.- Foster DC, Piekarz KH, MurantTI, LaPoint R, Haidaris CG, Philipps RP. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis. Am J Obstet Gynecol 2007;196(4):346.e1-8

40.- Foster DC, Sazenski TM, Stodgell CJ. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med 2004;49(7):503-9

41.- Halperin R, Zehavi S, Vaknin Z, Ben-Ami I, Pansky M, Schneider D. The major histopathologic characteristics in the vulvar vestibulitis syndrome. Gynecol Obstet Invest 2005;59(2):75-9.

42.- Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1999;48(4):270-5.

43.- Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur Pain 2004;8(2): 129-33.

44.- Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 2004;16(9):897-902.

45.- Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Torebjórk E. Psychophysical evidence of no-ciceptor sensitization in vulvar vestibulitis syndrome. Pain 2001 ;94(2): 177-83.

46.- Eide PK. Wind-up and the NMDA receptor complex from a clinical perpective. Eur J Pain 2000;4(1): 5-15.

47.- Bohm-Starke N, Hilliges M, Blomgren B, Falconer C, Rylander E. Increased blood flow and erythema in posterior vestibular mucosa in vulvar vestibulitis. Obstet Gynecol 2001 ;98(6): 1067-74.

48.- Ashman RB, Papadimitriou JM, Ott AK, Warmington JR. Antigens and immune response in Candida albi-cans infection.Immunol Cell Biol 1990;68(Pt 1):1-13.

49.- Franklyn KM, Warmington JR, Ott AK, Ashman RB. An immunodominant antigen of Candida albicans shows homology to the enzyme enolase. Immunol Cell Biol 1990;68(Pt3):173-178.

50.- Marinoff S, Turner M. Hypersensivity of vaginal candidiasis or treatment vehicles in the pathogene-sis of minor vestibular gland syndrome. J Reprod 1986;31(9):796-799.

51.- Foster DC, Dworkin RH, Wood RW. Effects of intra-dermal foot and 52. forearm capsaicin injection in normal and vulvodynia-afflicted women. Pain 2005;117(1-2): 128-36.

52.- Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely RH. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol 2004;104(1):126-33.

53.- Pukall CF, Binik YM, Khalife S, Amsel R, Abbott FV. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain 2002;96(1-2):163-75.

54.- Granot M. Personality traits associated with perception of noxious stimuli in women with vulvar vestibulitis syndrome. J Pain 2005;6(3): 168-73.

55.- Foster DC, Robinson JC, Davis KM. Urethral pressure variation in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 1993;169(1):107-12.

56.- Bornstein J, Shapiro S, Rahat M, Goldshmid N, Goldik Z, Abramovic, eta!. Polymerase chain reaction search for viral etiology of vulvar vestibulitis syndrome. Am J Obstet Gynecol 1996; 175(1): 139-44.

57.-  Morin C, Bouchard C, Brisson J, Fortier M, Blanchet-te C, Meisels A. Human papillomaviruses and vulvar vestibulitis. Obstet Gynecol 2000;95(5):683-7.

58.- Gaunt G, Good AE, McGovern RM, Stanhope CR, Gostout BS. Human papillomavirus in vulvar vestibulitis syndrome. J Reprod Med 2007;52(6):485-9.

59.- Oates JK.. Focal vulvitis and localised dyspareunia. Genitourin Med 1990;66(1):28-30.

60.- Damsted-Petersen C, Boyer SC, Pukall CF. Current perspectives in vulvodynia. Womens Health (Lond Engl) 2009;5(4):423-436.

61.- Ramirez De Knott HM, McCormick TS, Do SO, Goodman W, Ghannoum MA, Cooper KD, Nedorost ST.Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Dermatitis. 2005 Oct; 53(4):214-8.

62.- Baggish, M.S., Sze, E.H.M. and Johnson, R., Urinary oxalate excretion and its role in vulvar pain syndrome, American Journal of Obstetrics and Gynecology, 177 (1997) 507-511.

63.- Orlandi A, Francesconi A, Angeloni C, Palmieri G, Fulvia G, Ciotti M, et al. Prevalence and genotyping of human papillomavirus infection in women with vulvodynia. Acta Obstet Gynecol Scand 2007; 86:1003-10.

64.- Gunter J, Smith-King M, Collins J, Tawfik O.Vulvodynia: in situ hybridization analysis for human papillomavirus. Prim Care Update Ob Gyns. 1998 Jul 1;5(4):152.

65.- Prayson RA, Stoler MH, Hart WR. Vulvar vestibulitis. A histopathologic study of 36 cases, including human papillomavirus in situ hybridization analysis. Am J Surg Pathol 1995; 19:154-60.

66.- Morin C, Bouchard C, Brisson J, Fortier M, Blanchette C, Meisels A. Human  papillomaviruses and vulvar vestibulitis. Obstet Gynecol 2000; 95:683-7.

67.- Basson, R., Vulvar vestibulitis syndrome: a common condition which may present as vaginismus, Sex and Marital Therapy, 9 (1994) 221-224

68.- Mascherpa F, Bogliatto F, Lynch PJ, Micheletti L, Benedetto C. Vulvodynia as a possible somatization disorder. More than just an opinion. J Reprod Med 2007; 52:107-10.

69.- Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol. 2003 May; 148(5):1021-7.

70.- Eva LJ, MacLean AB, Reid WM, Rolfe KJ, Perrett CW. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol 2003; 189:458-61.

71.- Lotery HE, McClure N, Galask RP. Vulvodinia. Lancet 2004; 363:1058-60.

72.- Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely RH. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol. 2004 Jul; 104(1):126-33.

73.- Omoigui S.The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 – inflammatory profile of pain syndromes.Med Hypotheses. 2007; 69(6):1169-78. Epub 2007 Aug 28.

74.- Gordon AS, Panahian-Jand M, McComb F, Melegari C, Sharp S. Characteristics of women with vulvar pain disorders: responses to a Web-based survey. J Sex Marital Ther 2003; 29(Suppl 1):45-58.

75.- Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol 2007; 177:450-6.

76.- Eide PK. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain 2000; 4:5-15.

77.- Med Hypotheses. 2007; 69(2):282-6.

78.- Yoon H, Chung WS, Shim BS. Botulinum toxin A for the management of vulvodynia. Int J Impot Res. 2007 Jan-Feb; 19(1):84-7.

79.- Nguyen RH, Swanson D, Harlow BL. Urogenital infections in relation to the occurrence of vulvodynia. J Reprod Med 2009;54(6):385-92.

80.- Ponte M, Klemperer E, Sahay A, Chren MM. Effects of vulvodynia on quality of life. J Am Acad Dermatol 2009;60(1):70-6.

81.- Smith EM, Ritchie JM, Galask R, Pugh EE, Jia J, Ricks-McGillan J. Case-control study of vulvar vestibulitis risk associated with genital infections. Infect Dis Obstet Gynecol 2002; 10(4): 193-202.

82.- Oaklander AL, Rissmiller JG. Postherpetic neuralgia after shingles: an under-recognized cause of chronic vulvar pain. Obstet Gynecol 2002;99(4):625-8.

83.- Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61(5):310-316.

84.- Gardella B, Porru D, Ferdeghini F, Martinotti Gabe-lleotti E, Nappi RE, Rovereto B, et al. Insight into urogynecologic features of women with instertitial cistitis/ painful bladder. Eur Urol 2008;54(5): 1145-51

85.- Carrico DJ, Sherer KL, Peters KM. The relationship of interstitial cystitis/painful bladder syndrome to vulvodynia. Urol Nurs2009;29(4):233-8.

86.- Engman M, Wijma K, Wijma B. Itch and burning pain in women with partial vaginismus with or without vulvar vestibulitis. J Sex Marital Ther 2007;33(2):171-86.

87.- Goetsch MF. Surgery combined with muscle therapy for dyspareunia from vestibulitis: an observational study. J Reprod Med 2007;52(7):597-603

88.- Ter Kuile MM, Van Lankveld JJ, Vlieland CV, Willekes C, Weijenborg PT. Vulvar vestibulitis syndrome: an important factor in the evaluation of lifelong vaginismus? J Psychosom Obstet Gynaecol 2005;26(4):245-9.

89.- Danielsson I, Sjoberg I, Wikman M. Vulvar vestibulitis: medical, pschosexual and psychosocial aspects, a casecontrol study. Acta Obstet Gynecol Scand 2000;79(10):872-878.

90.- Raiteri R, Sinicco A, Pippione M, Tomasini C, Solaroli C, Vitale L, eta!. Vulvodynia and HIV: causal or casual association? Genitourin Med 1997;73(6):545-7.

91.- Ter Kuile MM, Van Lankveld JJ, Vlieland CV, Willekes C, Weijenborg PT. Vulvar vestibulitis syndrome: an important factor in the evaluation of lifelong vaginismus? J Psychosom Obstet Gynaecol 2005;26(4):245-9.

92.- Danielsson I, Sjoberg I, Wikman M. Vulvar vestibulitis: medical, pschosexual and psychosocial aspects, a casecontrol study. Acta Obstet Gynecol Scand 2000;79(10):872-878.

93.- Raiteri R, Sinicco A, Pippione M, Tomasini C, Solaroli C, Vitale L, eta!. Vulvodynia and HIV: causal or casual association? Genitourin Med 1997;73(6):545-7.

94.- Edward SK, Bates CM, Lewis F. 2014 UK national guideline on the management of vulvar conditions Int J STD AIDS 2014; 0(0) 1-14.

95.-  Stav K, Dwyer PL, Roberts L. Pudendal neuralgia. Fact or fiction? Obstet Gynecol Surv. 2009;64:190—9.

96.- Gabrielli C, Olave E. Aspectos anatómicos y topográficos del nervio pudendo en la región glútea. Int J Morphol. 2011;29:168—73.

97.- Itza Santos F, Salinas J, Zarza D, Gómez Sancha F, Allona Almagro A. Update in pudendal nerve entrapment syndrome: an approach anatomic-surgical, diagnostic and therapeutic. Actas Urol Esp. 2010 Jun;34(6):500-9.

98.- Gabrielli C, Olave E. Aspectos anatomicos y topograficos del nervio pudendo en la region glutea. Int. J. Morphol. 2011;29(1):168-173.

99.- de Barutell , C ; Contreras , D ; Rodríguez , M ; Muriel , C ; Camba , A ; González-Escalada , J R ; :Validación del índice de Lattinen para la evaluación del paciente con dolor crónico. Rev Soc Esp Dolor 19 (2012);4 :181-188.

100.- Netter H. Atlas de anatomía humana. 5ª ed. Elsevier-masson, Madrid

Autor: Dra. Susana Martínez Calvo

Tutor: Dra Mª Isabel Heraso Aragón

 

 

                                                                                                               

 

 


Consulta Dra Heraso


Información y petición de cita en la Unidad del Dolor de la Dra. Heraso.

 ¿Te quedan preguntas personalizadas sobre este tema?

Plantea tu propia pregunta

 

Es muy importante que el paciente invierta en su salud, es una prioridad. La inversión es a todos los niveles, incluido la adquisición de conocimientos sobre el dolor correspondiente. ¿Cuanto invierte una persona en su formación profesional? pues esto es igual o más importante, en esto le va la vida.